Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DFTX Definium Therapeutics

Pre-Mkt 08-10 04:40:21 EDT

46.14

+0.00

0.00%

盘前47.00

+0.86+1.86%

04:03 EDT

High49.70	Low44.24	Vol2.55M
Open46.30	D1 Closing46.14	Amplitude11.83%
Mkt Cap6.20B	Tradable Cap6.09B	Total Shares134.37M
T/O117.85M	T/O Rate1.93%	Tradable Shares132.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":46.14,"timestamp":1786132800000,"preClose":46.14,"halted":0,"volume":2547272,"hourTrading":{"tag":"盘前","latestPrice":47,"preClose":46.14,"latestTime":"04:03 EDT","volume":279,"amount":13032.903005999999,"timestamp":1786348984760,"change":0.86,"changeRate":0.018639,"amplitude":0.029692},"delay":0,"changeRate":0,"floatShares":132000000,"shares":134366950,"eps":-3.482311,"marketStatus":"Pre-Mkt","change":0,"latestTime":"08-10 04:40:21 EDT","open":46.3,"high":49.7,"low":44.24,"amount":117846135.92460799,"amplitude":0.118336,"askPrice":46.99,"askSize":64,"bidPrice":45.51,"bidSize":64,"shortable":3,"etf":0,"ttmEps":-3.482311,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1786368600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":46.14,"preHourTrading":{"tag":"盘前","latestPrice":47,"preClose":46.14,"latestTime":"04:03 EDT","volume":279,"amount":13032.903005999999,"timestamp":1786348984760,"change":0.86,"changeRate":0.018639,"amplitude":0.029692},"postHourTrading":{"tag":"盘后","latestPrice":45.6365,"preClose":46.14,"latestTime":"19:54 EDT","volume":39349,"amount":1815538.0777,"timestamp":1786146889087,"change":-0.5035,"changeRate":-0.010912,"amplitude":0.028977},"volumeRatio":1.4033678112179124,"optionData":{"bulkOrders":[{"symbol":"DFTX","call":false,"expireDate":1787284800000,"strike":"40.0","timestamp":1786111325483,"price":3.17,"volume":2400,"amount":760800,"type":"+"}]},"impliedVol":1.2162,"impliedVolPercentile":0.8429},"requestUrl":"/m/hq/s/DFTX","defaultTab":"news","newsList":[{"id":"2658676240","title":"Definium Therapeutics (DFTX) Is Up 6.0% After Strong DT120 Data Amid Wider Q2 Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658676240","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658676240?lang=en_us&edition=fundamental","pubTime":"2026-08-09 07:26","pubTimestamp":1786231608,"startTime":"0","endTime":"0","summary":"In the past week, Definium Therapeutics, Inc. reported a wider Q2 2026 net loss of US$158.99 million with basic and diluted loss per share of US$1.44, while also highlighting strong Phase III DT120 ODT data in major depressive disorder and progress toward pivotal generalized anxiety disorder readouts.\nThe company also released a large real‑world claims analysis showing high discontinuation and switching rates in generalized anxiety disorder treatment, underscoring substantial unmet need that...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-is-up-60-after-strong-dt120-data","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-dftx/definium-therapeutics/news/definium-therapeutics-dftx-is-up-60-after-strong-dt120-data","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657716621","title":"Definium Therapeutics: Buy Rating Reiterated on Strong Clinical and Financial Positioning; $74 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2657716621","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657716621?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:55","pubTimestamp":1786143329,"startTime":"0","endTime":"0","summary":"Justin Walsh, an analyst from JonesTrading, reiterated the Buy rating on Definium Therapeutics. The associated price target remains the same with $...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/definium-therapeutics-buy-rating-reiterated-on-strong-clinical-and-financial-positioning-74-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/definium-therapeutics-buy-rating-reiterated-on-strong-clinical-and-financial-positioning-74-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657230536","title":"Definium Therapeutics (DFTX) Gets a Buy from Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2657230536","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657230536?lang=en_us&edition=fundamental","pubTime":"2026-08-08 03:16","pubTimestamp":1786130179,"startTime":"0","endTime":"0","summary":"Jefferies analyst Andrew Tsai maintained a Buy rating on Definium Therapeutics today and set a price target of $65.00. According to TipRanks, Tsai ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/definium-therapeutics-dftx-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/definium-therapeutics-dftx-gets-a-buy-from-jefferies-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657628806","title":"Definium Therapeutics Price Target Raised to $75.00/Share from $73.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2657628806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657628806?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:12","pubTimestamp":1786122720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657660316","title":"Ami Fadia Reiterates Buy on Definium Therapeutics, Keeps $50 Price Target Ahead of Key GAD Phase 3 Readouts","url":"https://stock-news.laohu8.com/highlight/detail?id=2657660316","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657660316?lang=en_us&edition=fundamental","pubTime":"2026-08-07 09:35","pubTimestamp":1786066526,"startTime":"0","endTime":"0","summary":"Analyst Ami Fadia from Needham reiterated a Buy rating on Definium Therapeutics and keeping the price target at $50.00. Ami Fadia has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ami-fadia-reiterates-buy-on-definium-therapeutics-keeps-50-price-target-ahead-of-key-gad-phase-3-readouts-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ami-fadia-reiterates-buy-on-definium-therapeutics-keeps-50-price-target-ahead-of-key-gad-phase-3-readouts-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657645256","title":"Definium Therapeutics Posts Strong Phase 3 Data and Capital Raise to Fund Psychedelic Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2657645256","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657645256?lang=en_us&edition=fundamental","pubTime":"2026-08-07 07:33","pubTimestamp":1786059234,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) just unveiled an announcement. Definium Therapeutics reported that its Phase 3 Emerge trial of DT120 ODT in major...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-posts-strong-phase-3-data-and-capital-raise-to-fund-psychedelic-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-posts-strong-phase-3-data-and-capital-raise-to-fund-psychedelic-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657966523","title":"Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2657966523","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657966523?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:09","pubTimestamp":1786050595,"startTime":"0","endTime":"0","summary":"Earnings Flash (DFTX) Definium Therapeutics Posts Q2 EPS -$1.44, vs. FactSet Est of -$0.54","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657663039","title":"Definium Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657663039","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657663039?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050110,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryDefinium Therapeutics IncDFTX.OQreported a quarterly adjusted loss of $1.44 per share for the quarter ended Ju","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502456","title":"Definium Therapeutics reports Q2 EPS ($1.44), consensus (53c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502456","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502456?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047479,"startTime":"0","endTime":"0","summary":"of June 30, 2026, Definium Therapeutics (DFTX) had cash, cash equivalents and investments of approximately $1.1 billion compared to $411.6 million ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-reports-q2-eps-1-44-consensus-53c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-reports-q2-eps-1-44-consensus-53c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650957","title":"Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650957","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650957?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047436,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Q2 net loss widens on higher warrant costsOverviewUS biopharma firm's Q2 net loss widens, driven by higher warrant liabilities and expensesCompany raised $805 mln in public offer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","IBRN","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0109394709.USD","BK4007","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4139","PRAX","VTVT","DTIL","IE0009355771.USD","DFTX","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657465751","title":"Definium Net Loss More than Doubled to $159 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2657465751","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657465751?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046756,"startTime":"0","endTime":"0","summary":"Definium net loss more than doubled to $159 million in Q2 FY26Definium Therapeutics posted a Q2 net loss of $159 million versus $42.7 million a year earlier, driven by an $86.2 million non-cash warran","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3WWV91:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652717","title":"Definium Therapeutics Inc Q2 Net Income USD -158.986 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652717","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652717?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046521,"startTime":"0","endTime":"0","summary":"BRIEF-Definium Therapeutics Inc Q2 Net Income USD -158.986 MillionAug 06 (Reuters) - Definium Therapeutics Inc Q2 income from operations USD -75.077 million.Q2 EPS USD -1.44Q2 operating expenses USD 75.077 millionQ2 basic EPS USD -1.44","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLX34K6CB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657266652","title":"Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657266652","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657266652?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046496,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/DFTX","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Definium Therapeutics Q2 EPS $(1.44) Misses $(0.55) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657654259","title":"Definium Therapeutics, Inc. options imply 14.8% move in share price post-earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2657654259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657654259?lang=en_us&edition=fundamental","pubTime":"2026-08-07 03:20","pubTimestamp":1786044030,"startTime":"0","endTime":"0","summary":"Pre-earnings options volume in Definium Therapeutics (DFTX), Inc. is 6.7x normal with calls leading puts 84:1. Implied volatility suggests the mark...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-options-imply-14-8-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/definium-therapeutics-inc-options-imply-14-8-move-in-share-price-post-earnings-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DECU","JOYT","PMDE","FEBU","VGFPF","RGLO","DFTX","VOTE","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657656759","title":"Definium Therapeutics Sets August 6 Date to Report Q2 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657656759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657656759?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:00","pubTimestamp":1786035616,"startTime":"0","endTime":"0","summary":"An announcement from Definium Therapeutics ( ($DFTX) ) is now available. Definium Therapeutics, Inc. said it will report its second-quarter 2026 fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-sets-august-6-date-to-report-q2-2026-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-sets-august-6-date-to-report-q2-2026-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655014","title":"Definium Therapeutics Issues Equity Inducement Grants to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655014","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655014?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:14","pubTimestamp":1786032850,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has provided an announcement. Definium Therapeutics has granted stock options to eight newly hired non-executive ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-equity-inducement-grants-to-new-hires?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-issues-equity-inducement-grants-to-new-hires?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DFTX","BK4007","EQR","BK4215","REZ","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657655099","title":"Definium Therapeutics Launches GAD Education Platform Wired for Worry","url":"https://stock-news.laohu8.com/highlight/detail?id=2657655099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657655099?lang=en_us&edition=fundamental","pubTime":"2026-08-07 00:13","pubTimestamp":1786032781,"startTime":"0","endTime":"0","summary":"Definium Therapeutics ( ($DFTX) ) has provided an announcement. Definium Therapeutics has launched Wired for Worry, a disease education platform fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-launches-gad-education-platform-wired-for-worry?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/definium-therapeutics-launches-gad-education-platform-wired-for-worry?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657871598","title":"Definium Therapeutics Inc Expected to Post a Loss of 55 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2657871598","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657871598?lang=en_us&edition=fundamental","pubTime":"2026-08-05 06:21","pubTimestamp":1785882068,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Inc <DFTX.OQ> expected to post a loss of55cents a share - Earnings PreviewDefinium Therapeutics IncDFTX.OQDFTX.Ois expected to  show no change in quarterly revenue when it report","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4413FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656309732","title":"Definium Therapeutics Issues Inducement Options for 115,600 Shares to Six New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2656309732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656309732?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:01","pubTimestamp":1785787271,"startTime":"0","endTime":"0","summary":"Definium Therapeutics issues inducement options for 115,600 shares to six new hiresDefinium Therapeutics issued inducement stock options covering 115,600 common shares to six newly hired non-executive","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9lB9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655389313","title":"Press Release: Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655389313","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655389313?lang=en_us&edition=fundamental","pubTime":"2026-07-31 04:50","pubTimestamp":1785444600,"startTime":"0","endTime":"0","summary":"NEW YORK--(BUSINESS WIRE)--July 30, 2026--Definium Therapeutics, Inc. (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address un","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.definiumtx.com;ir.definiumtx.com","stockEarnings":[{"period":"1week","weight":0.0602},{"period":"1month","weight":0.0181},{"period":"3month","weight":1.0925},{"period":"6month","weight":1.7302},{"period":"1year","weight":3.6186},{"period":"ytd","weight":2.4459}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.130491},{"month":2,"riseRate":0.8,"avgChangeRate":0.136845},{"month":3,"riseRate":0.4,"avgChangeRate":0.072082},{"month":4,"riseRate":0.8,"avgChangeRate":0.037703},{"month":5,"riseRate":0.5,"avgChangeRate":0.01554},{"month":6,"riseRate":0.5,"avgChangeRate":0.064762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.160554},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.066256},{"month":9,"riseRate":0.2,"avgChangeRate":-0.174855},{"month":10,"riseRate":0.6,"avgChangeRate":0.009639},{"month":11,"riseRate":0.4,"avgChangeRate":0.026551},{"month":12,"riseRate":0.4,"avgChangeRate":-0.08416}],"exchange":"NASDAQ","name":"Definium Therapeutics","nameEN":"Definium Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Definium Therapeutics,DFTX,Definium Therapeutics股票,Definium Therapeutics股票老虎,Definium Therapeutics股票老虎国际,Definium Therapeutics行情,Definium Therapeutics股票行情,Definium Therapeutics股价,Definium Therapeutics股市,Definium Therapeutics股票价格,Definium Therapeutics股票交易,Definium Therapeutics股票购买,Definium Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Definium Therapeutics(DFTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Definium Therapeutics(DFTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}